Oropouche Virus: a Re-Emerging Arbovirus of Clinical Significance
| dc.contributor.author | Desai A.N. | |
| dc.contributor.author | Otter A. | |
| dc.contributor.author | Koopmans M. | |
| dc.contributor.author | Granata G. | |
| dc.contributor.author | Grobusch M.P. | |
| dc.contributor.author | Tunali V. | |
| dc.contributor.author | Astorri R. | |
| dc.date.accessioned | 2024-11-25T16:53:55Z | |
| dc.date.available | 2024-11-25T16:53:55Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | [No abstract available] | en_US |
| dc.description.sponsorship | National Science Foundation, NSF, (SES2200228); National Science Foundation, NSF; Danmarks Grundforskningsfond, DNRF, (DNRF170, 101102733); Danmarks Grundforskningsfond, DNRF | en_US |
| dc.identifier.doi | 10.1016/j.ijid.2024.107251 | |
| dc.identifier.issn | 1201-9712 | |
| dc.identifier.scopus | 2-s2.0-85207030074 | |
| dc.identifier.uri | https://doi.org/10.1016/j.ijid.2024.107251 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/5612 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier B.V. | en_US |
| dc.relation.ispartof | International Journal of Infectious Diseases | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | alpha interferon | en_US |
| dc.subject | mycophenolic acid | en_US |
| dc.subject | ribavirin | en_US |
| dc.subject | virus vaccine | en_US |
| dc.subject | Arbovirus | en_US |
| dc.subject | arbovirus infection | en_US |
| dc.subject | clinical feature | en_US |
| dc.subject | clinical significance | en_US |
| dc.subject | disease re-emergence | en_US |
| dc.subject | Editorial | en_US |
| dc.subject | geographic distribution | en_US |
| dc.subject | human | en_US |
| dc.subject | nonhuman | en_US |
| dc.subject | Oropouche virus | en_US |
| dc.subject | real time polymerase chain reaction | en_US |
| dc.subject | vaccination | en_US |
| dc.subject | virus transmission | en_US |
| dc.title | Oropouche Virus: a Re-Emerging Arbovirus of Clinical Significance | en_US |
| dc.type | Editorial | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | … | |
| gdc.author.scopusid | 57211975966 | |
| gdc.author.scopusid | 57217005064 | |
| gdc.author.scopusid | 7006736989 | |
| gdc.author.scopusid | 57199155264 | |
| gdc.author.scopusid | 7004891682 | |
| gdc.author.scopusid | 57194484508 | |
| gdc.author.scopusid | 57196192549 | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::editorial | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | Desai A.N., Division of Infectious Diseases, University of California Davis Health, Sacramento, 95817, CA, United States; Otter A., Emerging Pathogen Serology group, Vaccine Development and Evaluation Centre, UK Health Security Agency, Porton Down, Salisbury, United Kingdom, NIHR Health Protection Research Unit in Emerging Zoonotic Infections, United Kingdom; Koopmans M., Viroscience Department, Pandemic and Disaster Preparedness Centre, ErasmusMC, Rotterdam, Netherlands; Granata G., Systemic and Immune Depression-Associated Infection Unit, Clinical and Research Department, National Institute for Infectious Diseases “L. Spallanzani”, IRCCS, Rome, 00149, Italy; Grobusch M.P., Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam Infection & Immunity, Amsterdam Public Health – Global Health, University of Amsterdam, Amsterdam, Netherlands; Tunali V., Faculty of Medicine, Department of Microbiology, Izmir University of Economics, Turkey; Astorri R., Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania “Luigi Vanvitelli”, Naples, 80131, Italy; Jokelainen P., Infectious Disease Pre | en_US |
| gdc.description.publicationcategory | Diğer | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.volume | 149 | en_US |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4402828259 | |
| gdc.identifier.pmid | 39507390 | |
| gdc.index.type | Scopus | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 8.0 | |
| gdc.oaire.influence | 2.9183083E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Editorial | |
| gdc.oaire.keywords | SDG 3 - Good Health and Well-being | |
| gdc.oaire.keywords | Internal Medicine - Radboud University Medical Center | |
| gdc.oaire.keywords | Infectious and parasitic diseases | |
| gdc.oaire.keywords | RC109-216 | |
| gdc.oaire.popularity | 8.480113E-9 | |
| gdc.oaire.publicfunded | true | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 2.4028 | |
| gdc.openalex.normalizedpercentile | 0.89 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 13 | |
| gdc.plumx.newscount | 1 | |
| gdc.plumx.pubmedcites | 1 | |
| gdc.plumx.scopuscites | 5 | |
| gdc.scopus.citedcount | 5 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |